Exploring the role of lipids and mitochondria in heart and metabolic diseases
2024 Kern Lipid Conference: "Lipids and Mitochondria in Cardiometabolic Diseases"
The 2024 Kern Lipid Conference is a friendly gathering for scientists to talk about how fats in our bodies and tiny energy factories called mitochondria affect health issues like obesity, diabetes, and heart disease, with the goal of inspiring new researchers and encouraging teamwork in understanding these important topics.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11000581 on NIH RePORTER |
What this research studies
The 2024 Kern Lipid Conference will focus on the relationship between lipids and mitochondria in various cardiometabolic diseases. This event will bring together established and emerging scientists to share insights and research findings related to lipid metabolism and mitochondrial function. Participants will engage in discussions about how these factors contribute to conditions like obesity, diabetes, and cardiovascular diseases. The conference aims to inspire young researchers and foster collaboration across different fields of metabolic science.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals affected by obesity, diabetes, and cardiovascular diseases.
Not a fit: Patients with unrelated metabolic disorders or those not affected by cardiometabolic diseases may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights that improve the understanding and treatment of cardiometabolic diseases.
How similar studies have performed: Previous conferences and research in lipid metabolism and mitochondrial function have shown promising results, indicating that this approach is both relevant and potentially impactful.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Brestoff, Jonathan R — Washington University
- Study coordinator: Brestoff, Jonathan R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.